Anti–vascular endothelial growth factor therapy
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF therapy or anti-VEGF medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab, antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib, sorafenib, axitinib, and pazopanib. (Some of these therapies target VEGF receptors rather than the VEGFs.)
known for
treatment
Acute visual lossAngioid streaksAnti-VEGF agentsAnti-VEGF medicationAnti-VEGF therapyAnti-vascular endothelial growth factor therapyAnti vascular endothelial growth factor therapyAtul Kumar (ophthalmologist)BevacizumabCapillaryConberceptDiabetic papillopathyEncephalopathyGlaucomaIntravitreal injectionJoan MillerLaser coagulationMacular degenerationPachychoroid disorders of the maculaPatricia D'AmoreRetinaRetinopathy of prematuritySickle cell retinopathy
Link from a Wikipage to another Wikipage
primaryTopic
Anti–vascular endothelial growth factor therapy
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF therapy or anti-VEGF medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab, antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib, sorafenib, axitinib, and pazopanib. (Some of these therapies target VEGF receptors rather than the VEGFs.)
has abstract
Anti–vascular endothelial grow ...... dema symptoms over six months.
@en
Wikipage page ID
48,878,156
page length (characters) of wiki page
Wikipage revision ID
1,023,792,685
Link from a Wikipage to another Wikipage
date
February 2018
@en
name
Anti–vascular endothelial growth factor therapy
@en
reason
both are now approved drugs, b ...... ng trials for this indication?
@en
specialty
oncology
@en
wikiPageUsesTemplate
subject
comment
Anti–vascular endothelial grow ...... eptors rather than the VEGFs.)
@en
label
Anti–vascular endothelial growth factor therapy
@en